Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 15 (May 20), 2005: pp. 3455-3464
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.04.050

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calzone, K. A.
Right arrow Articles by Kirsch, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calzone, K. A.
Right arrow Articles by Kirsch, I. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Randomized Comparison of Group Versus Individual Genetic Education and Counseling for Familial Breast and/or Ovarian Cancer

Kathleen A. Calzone, Sheila A. Prindiville, Oxana Jourkiv, Jean Jenkins, Maria DeCarvalho, Dawn B. Wallerstedt, David J. Liewehr, Seth M. Steinberg, Peter W. Soballe, Stan Lipkowitz, Pamela Klein, Ilan R. Kirsch

From the Genetics Branch, Center for Cancer Research; Orkand Corporation, Contractor; Center for Cancer Research, Biostatistics and Data Management Section; Center for Cancer Research, Laboratory of Cellular and Molecular Biology; National Cancer Institute, National Institutes of Health; National Center for Complementary and Alternative Medicine, National Institutes of Health; Uniformed Services University, Bethesda, MD; and Genentech, Inc, San Francisco, CA

Address reprint requests to Kathleen A. Calzone, RN, MSN, APNG, National Cancer Institute, Center for Cancer Research, Genetics Branch, 8901 Wisconsin Ave, Bldg 8, Rm 5101, Bethesda, MD 20889-5105; e-mail: calzonek{at}mail.nih.gov

PURPOSE: An efficient approach to education and counseling before BRCA1 and BRCA2 mutation testing is necessary for effective utilization of testing in the community. Education and counseling, when delivered individually, are limited by a shortage of trained health care providers as well as by financial and time constraints. The purpose of this study was to determine whether pretest education and counseling for breast cancer genetics in a group setting is equivalent to that provided on an individual basis.

PATIENTS AND METHODS: One hundred forty-two patients at high risk for harboring a BRCA mutation were randomly assigned to group or individual education and counseling sessions. Group education was followed by brief individual counseling. Knowledge and Impact of Events Scales (IES) were administered at baseline and after education and counseling and at 1 week and 3, 6, and 12 months. Satisfaction with education and counseling was measured at completion of the session. Preferred method of education and counseling was solicited at 3 months.

RESULTS: There was no difference in knowledge or IES scores between groups. When stratified by genetic test results, knowledge scores showed no difference. Regardless of group, post-test IES scores in patients with positive results were higher than patients with negative or uninformative results but returned to baseline by 12 months. Participants were equally satisfied with either method they were assigned. Significantly more time was spent per patient in individual sessions (1.25 hours) than in group education (0.74 hours).

CONCLUSION: Our data suggest that group education and counseling may confer similar benefits compared with traditional individual sessions. Additional investigation of this approach in larger numbers of patients is warranted.

Supported by National Cancer Institute; The Chief, Navy Bureau of Medicine and Surgery, Washington, DC, Clinical Investigation Program No. B99-015.

Authors' disclosures of potential conflicts of interest are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online